<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Neurodegener</journal-id><journal-id journal-id-type="iso-abbrev">Mol Neurodegener</journal-id><journal-title-group><journal-title>Molecular Neurodegeneration</journal-title></journal-title-group><issn pub-type="epub">1750-1326</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3850656</article-id><article-id pub-id-type="publisher-id">1750-1326-8-S1-P54</article-id><article-id pub-id-type="doi">10.1186/1750-1326-8-S1-P54</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Leaky Ryanodine receptors increases Amyloid-beta load and induces memory impairments in Tg2576 mouse model of Alzheimer disease</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Oul&#x000e8;s</surname><given-names>B&#x000e9;n&#x000e9;dicte</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Del Prete</surname><given-names>Dolores</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Greco</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Zhang</surname><given-names>Xuexin</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Lauritzen</surname><given-names>Inger</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Trebak</surname><given-names>Mohamed</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Benfenati</surname><given-names>Fabio</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Checler</surname><given-names>Fr&#x000e9;d&#x000e9;ric</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A9"><name><surname>Chami</surname><given-names>Mounia</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib></contrib-group><aff id="I1"><label>1</label>INSERM U 807, Paris V University, F-75015 Paris, France</aff><aff id="I2"><label>2</label>Neuroscience and Brain Technologies - Istituto Italiano di Tecnologia, 16163 Genova, Italy</aff><aff id="I3"><label>3</label>Institut de Pharmacologie Mol&#x000e9;culaire et Cellulaire, UMR7275 CNRS/UNSA, 06560 Valbonne, France</aff><aff id="I4"><label>4</label>Center for Cardiovascular Sciences, MC8, Albany Medical College, Albany, NY 12208; USA</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>4</day><month>10</month><year>2013</year></pub-date><volume>8</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Molecular Neurodegeneration: Basic biology and disease pathways</named-content><named-content content-type="supplement-sponsor">This supplement has not been sponsored.</named-content></supplement><fpage>P54</fpage><lpage>P54</lpage><permissions><copyright-statement>Copyright &#x000a9; 2013 Oul&#x000e8;s et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Oul&#x000e8;s et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.molecularneurodegeneration.com/content/8/S1/P54"/><conference><conf-date>10-12 September 2013</conf-date><conf-name>Molecular Neurodegeneration: Basic biology and disease pathways</conf-name><conf-loc>Cannes, France</conf-loc></conference></article-meta></front><body><sec><title>Background</title><p>In Alzheimer disease (AD), the perturbation of the endoplasmic reticulum (ER) calcium (Ca2+) homeostasis has been linked to presenilins (PS) [<xref ref-type="bibr" rid="B1">1</xref>], the catalytic core in gamma-secretase complexes cleaving the amyloid precursor protein (APP) thereby generating amyloid beta peptides. Here we investigate whether APP perturbs ER Ca2+ homeostasis and whether ER Ca2+ could in turn influence amyloid beta production.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><p>We used neuroblastoma SH-SY5Y cell lines stably overexpressing human APP695 cDNA harboring or not the Swedish double mutation (K670M&#x02192;N671L) (APPswe and APP695 respectively) and Tg2576 mice carrying human APPswe cDNA under the control of the hamster Prion promoter. We analyzed subcellular Ca2+ signals by using aequorin targeted Ca2+ probes, Fura2, AM dye and patch clamp experiments. We analyzed the expression of the Ryanodine receptor (RyR) by western blot and quantitative RT-PCR. We studied the impact of RyR blockade by dantrolene on APP metabolism and Amyloid beta peptide production using biochemistry, ELISA and immunohistochemistry approaches and investigated the underlying mechanisms through the study of APP phosphorylation, and beta- and gamma secretase expression and activities. We finally studied pre- and post-synaptic proteins expression and learning and memory paradigms in Tg2576 mice upon vehicle or dantrolene treatment.</p></sec><sec sec-type="results"><title>Results</title><p>We show that overexpression of APP695, or APPswe triggers increased Ryanodine receptors (RyR) expression and enhances RyR-mediated ER Ca2+ release in SH-SY5Y neuroblastoma cells and in APPswe-expressing (Tg2576) mice. Interestingly, dantrolene-induced lowering of RyR-mediated Ca2+ release leads to the reduction of both intracellular and extracellular amyloid beta load in neuroblastoma cells as well as in primary cultured neurons derived from Tg2576 mice. This A&#x003b2; reduction can be accounted for by decreased Thr-668-dependent APP phosphorylation and &#x003b2;- and gammaological lesions and slows down learning and memory deficits in Tg2576 mice [<xref ref-type="bibr" rid="B2">2</xref>].</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Overall, our data document a key role of RyR in A&#x003b2; production and learning and memory performances, and delineate RyR-mediated control of Ca2+ homeostasis as a physiological paradigm that could be targeted for innovative therapeutic approaches.</p></sec></body><back><sec><title>Acknowledgements</title><p>This work was supported by INSERM, CNRS, AFM, FRM, LABEX DISTALZ (excellence laboratory, program investment for the future), the National Institutes of Health, "L'Ecole de l'INSERM Liliane Bettencourt" for supporting the MD-PhD curriculum of B.O., and the Italian Institute of Technology, Genova, Italy.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Bezprozvanny</surname><given-names>I</given-names></name><name><surname>Mattson</surname><given-names>MP</given-names></name><article-title>Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease</article-title><source>Trends Neurosci</source><year>2008</year><volume>31</volume><fpage>454</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2008.06.005</pub-id><pub-id pub-id-type="pmid">18675468</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Oules</surname><given-names>B</given-names></name><name><surname>Del Prete</surname><given-names>D</given-names></name><name><surname>Greco</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Lauritzen</surname><given-names>I</given-names></name><name><surname>Sevalle</surname><given-names>J</given-names></name><name><surname>Moreno</surname><given-names>S</given-names></name><name><surname>Paterlini-Brechot</surname><given-names>P</given-names></name><name><surname>Trebak</surname><given-names>M</given-names></name><name><surname>Checler</surname><given-names>F</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name><name><surname>Chami</surname><given-names>M</given-names></name><article-title>Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease</article-title><source>J Neurosci</source><year>2012</year><volume>32</volume><fpage>11820</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0875-12.2012</pub-id><pub-id pub-id-type="pmid">22915123</pub-id></mixed-citation></ref></ref-list></back></article>